Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours
Options
PubMed ID
22843869
Description
Eight human catalytic phosphoinositide 3-kinase (PI3K) isoforms exist which are subdivided into three classes. While class I isoforms have been well-studied in cancer, little is known about the functions of class II PI3Ks.
Date of Publication
2012
Publication Type
Article
Language(s)
en
Contributor(s)
Boller, Danielle | |
Doepfner, Kathrin T | |
De Laurentiis, Angela | |
Guerreiro, Ana S | |
Marinov, Marin | |
Shalaby, Tarek | |
Depledge, Paul | |
Robson, Anthony | |
Saghir, Nahid | |
Hayakawa, Masahiko | |
Kaizawa, Hiroyuki | |
Koizumi, Tomonobu | |
Ohishi, Takahide | |
Fattet, Sarah | |
Delattre, Olivier | |
Schweri-Olac, Anelia | |
Grotzer, Michael A | |
Frei, Karl | |
Spertini, Olivier | |
Waterfield, Michael D |
Additional Credits
Series
Anticancer research
Publisher
International Inst. of Anticancer Research
ISSN
0250-7005
Access(Rights)
metadata.only